-
Mashup Score: 21Omega-3 fatty acids for cardiovascular event lowering - 9 month(s) ago
Abstract. Low-density lipoprotein cholesterol (LDL-C) is the main target for therapeutics aimed at reducing the risk of atherosclerotic cardiovascular disease (
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 203Omega-3 fatty acids for cardiovascular event lowering - 9 month(s) ago
Abstract. Low-density lipoprotein cholesterol (LDL-C) is the main target for therapeutics aimed at reducing the risk of atherosclerotic cardiovascular disease (
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet-
Our review on Omega-3 fatty acids for cardiovascular event lowering, now out in @ESC_Journals 🔗https://t.co/aM10J7SJxl Thank you @DLBHATTMD for your mentorship! https://t.co/wGktEWvVTM
-
-
Mashup Score: 2Sex differences in trends and outcomes of acute myocardial infarction with mechanical complications in the United States - 9 month(s) ago
Mechanical complications (MC) are rare but significant sequelae of acute myocardial infarction (AMI). Current data on sex differences in AMI with MC is limited.We queried the National Inpatient Sam…
Source: www.tandfonline.comCategories: General Medicine News, CardiologistsTweet-
RT @FredRiveraMD: 🔥 Hot off the press https://t.co/WGK4pC3rMZ Thank you @avolgman @Nishant_ShahMD @MarkDLC_MD @Gurleen_Kaur96
-
-
Mashup Score: 39350. GLP-1 Agonists: Mechanisms to Applications with Dr. Dennis Bruemmer - 11 month(s) ago
The CardioNerds GLP-1 Agonists series discusses the mechanisms of action of this agent class with Dr. Dennis Bruemmer
Source: www.cardionerds.comCategories: General Medicine News, CardiologistsTweet-
Now out, @CardioNerds episode on GLP1 agonists with Dr. Bruemmer! And stay tuned for part 2 & 3 of the series Such an honor to work with the dream team @CFAndersenMD @RichardAFerraro 🔗 https://t.co/5cqTlVW1dm https://t.co/Re2Rvj61Ir
-
-
Mashup Score: 19Google Forms: Sign-in - 1 year(s) ago
Access Google Forms with a personal Google account or Google Workspace account (for business use).
Source: accounts.google.comCategories: General Medicine News, CardiologistsTweet-
Applications for the @CardioNerds Academy are due tonight! 🔗 https://t.co/iQcOUX20hu https://t.co/HdSJGF75Ft
-
-
Mashup Score: 19Google Forms: Sign-in - 1 year(s) ago
Access Google Forms with a personal Google account or Google Workspace account (for business use).
Source: accounts.google.comCategories: General Medicine News, CardiologistsTweet-
Applications for the @CardioNerds Academy are due tonight! 🔗 https://t.co/iQcOUX20hu https://t.co/HdSJGF75Ft
-
-
Mashup Score: 2
Home > CardioNerds > Lp(a) Therapeutics in Development – New Medications in the Armamentarium for ASCVD? Elevated lipoprotein (a) [Lp(a)] is an established risk factor for atherosclerotic cardiovascular disease (ASCVD), as demonstrated in several epidemiological, genome-wide association, and Mendelian randomization studies (1-3). However, to date, there are no available therapies that lead to a substantial reduction in Lp(a) and no clinical trial data to support that lowering Lp(a) reduces adverse cardiovas
Source: www.docwirenews.comCategories: Cardiologists, Latest HeadlinesTweet-
Lp(a) Therapeutics in Development‼️ Article in @mydocwire on @RonBlankstein’s talk at #ASPC2023 🔗 https://t.co/oMLsCSFZMs https://t.co/mPaluTv9ei https://t.co/9WhkRTJgGk
-
-
Mashup Score: 5
Home > CardioNerds > The South Asian Cardiometabolic Curse: A High-Risk Ethnic Population South Asian ethnicity is included as a risk-enhancing factor for atherosclerotic cardiovascular disease (ASCVD) in the most recent guidelines (1). The terminology South Asian refers to a diverse group of people from Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka. A higher prevalence of traditional risk factors combined with unhealthy lifestyle behaviors puts this population at a disproportionately
Source: www.docwirenews.comCategories: Cardiologists, Latest HeadlinesTweet-
The South Asian Cardiometabolic Curse?🫀 Article on @dranandrohatgi's talk at #ASPC2023 in @mydocwire 🔗https://t.co/Tga0UgFmxW https://t.co/pXYNGgok7n
-
-
Mashup Score: 1Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction - PubMed - 1 year(s) ago
Although there is an established bidirectional relationship between heart failure with reduced ejection fraction and liver disease, the association between heart failure with preserved ejection fraction (HFpEF) and liver diseases, such as nonalcoholic fatty liver disease (NAFLD), has not been well e …
Source: pubmed.ncbi.nlm.nih.govCategories: Cardiologists, Latest HeadlinesTweet-
2/ HFpEF & NAFLD #ASPC2023 3 phenotypes 🔺obstructive HFpE 🔺metabolic HFpEF 🔺advanced liver fibrosis HFpEF 🔗 https://t.co/bOwSOYXV7y https://t.co/ObcJNTaZra
-
-
Mashup Score: 11Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals - 1 year(s) ago
Background: Individuals of South Asian ancestry represent 23% of the global population, corresponding to 1.8 billion people, and have substantially higher risk of atherosclerotic cardiovascular disea
Source: www.ahajournals.orgCategories: Cardiologists, Latest HeadlinesTweet-
1/ High-risk ethnicity: Focus on South Asians #ASPC2023 @dranandrohatgi South Asians have excess coronary disease risk Cardiometabolic risk ‼️ 🔗 https://t.co/h6tYxN3by0 https://t.co/cCinJUmCMb
-
RT @ZHeart11768530: 💥Omega-3 fatty acids for cardiovascular event lowering #OpenAccess #2024Review @ESC_Journals https://t.co/KSzU6EvHNd #…